BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36597834)

  • 21. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Biegus J; Hillege HL; Postmus D; Valente MA; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Massie BM; Metra M; Teerlink JR; Voors AA; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2016 Jul; 18(7):830-9. PubMed ID: 27170455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy.
    Teal EN; Appiagyei A; Sheffield-Abdullah K; Manuck TA
    Pregnancy Hypertens; 2022 Jun; 28():88-93. PubMed ID: 35290940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preeclampsia: an update.
    Lambert G; Brichant JF; Hartstein G; Bonhomme V; Dewandre PY
    Acta Anaesthesiol Belg; 2014; 65(4):137-49. PubMed ID: 25622379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of fetal gender and the onset and severity of hypertensive disorders of pregnancy.
    Callais NA; Morgan JA; Leggio BA; Wang Y
    J Matern Fetal Neonatal Med; 2022 Jun; 35(12):2260-2265. PubMed ID: 32576066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study.
    Lisonkova S; Bone JN; Muraca GM; Razaz N; Wang LQ; Sabr Y; Boutin A; Mayer C; Joseph KS
    Am J Obstet Gynecol; 2021 Nov; 225(5):538.e1-538.e19. PubMed ID: 33974902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of delivery and neonatal outcomes with early preterm severe preeclampsia: does fetal growth restriction matter?
    Walia A; Berger VK; Gonzalez JM; Sobhani NC
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2208251. PubMed ID: 37137495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth Studies.
    Mateus J; Newman RB; Zhang C; Pugh SJ; Grewal J; Kim S; Grobman WA; Owen J; Sciscione AC; Wapner RJ; Skupski D; Chien E; Wing DA; Ranzini AC; Nageotte MP; Gerlanc N; Albert PS; Grantz KL
    Am J Obstet Gynecol; 2019 Dec; 221(6):635.e1-635.e16. PubMed ID: 31226296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimal gestational age to deliver patients with chronic hypertension on antihypertensive therapy.
    Jeganathan S; Blitz MJ; Makol AK; Juhel HS; Joseph A; Hentz R; Rochelson B; Rafael TJ
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2210727. PubMed ID: 37150597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe preterm preeclampsia: an examination of outcomes by race.
    Peterson JA; Sandgren K; Levine LD
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100181. PubMed ID: 33345907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
    Barton JR; Woelkers DA; Newman RB; Combs CA; How HY; Boggess KA; Martin JN; Kupfer K; Sibai BM;
    Am J Obstet Gynecol; 2020 Mar; 222(3):259.e1-259.e11. PubMed ID: 31518550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Hypertension Among Pregnant Women When Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines and Association With Maternal and Fetal Outcomes.
    Bello NA; Zhou H; Cheetham TC; Miller E; Getahun DT; Fassett MJ; Reynolds K
    JAMA Netw Open; 2021 Mar; 4(3):e213808. PubMed ID: 33787907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes before and after Adopting Guidelines for Expectant Management of Severe Preeclampsia.
    Sanjanwala AR; Jauk VC; Cozzi GD; Becker DA; Harper LM; Casey BM; Tita AT; Subramaniam A
    Am J Perinatol; 2022 Jan; 39(2):172-179. PubMed ID: 32702772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia.
    Kozic JR; Benton SJ; Hutcheon JA; Payne BA; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Oct; 33(10):995-1004. PubMed ID: 22014776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation.
    Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
    Am J Obstet Gynecol; 2000 Dec; 183(6):1475-9. PubMed ID: 11120513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.
    Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A
    Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertensive Disorders of Pregnancy.
    Farahi N; Oluyadi F; Dotson AB
    Am Fam Physician; 2024 Mar; 109(3):251-260. PubMed ID: 38574215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prepregnancy liver enzyme levels and risk of preeclampsia in a subsequent pregnancy: A population-based cohort study.
    Cho GJ; Kim HY; Park JH; Ahn KH; Hong SC; Oh MJ; Kim HJ
    Liver Int; 2018 May; 38(5):949-954. PubMed ID: 29094446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early delivery or expectant management for late preterm preeclampsia: A meta-analysis of randomized controlled trials.
    Chatzakis C; Liberis A; Zavlanos A; Petousis S; Tsakmaki E; Dinas K; Sotiriadis A
    Acta Obstet Gynecol Scand; 2021 Aug; 100(8):1392-1400. PubMed ID: 33742472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical approaches to evaluating hypertensive disorders of pregnancy.
    Knupp RJ; Subramaniam A; Tita ANT; Sinkey R; Battarbee AN
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100816. PubMed ID: 36396039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.